Literature DB >> 2527264

Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.

S Hori1, S Sato, S Kitagawa, T Azuma, S Kokudo, T Hamaoka, H Fujiwara.   

Abstract

The present study investigates the effects of i.v. presensitization with class II H-2-disparate allogeneic cells on various L3T4+ T cell functions including the capability of rejecting the corresponding allogeneic skin graft. C57BL/6 (B6) mice were i.v. presensitized with class II H-2 disparate B6-C-H-2bm12 (bm12) spleen cells. Such presensitization did not affect the bm12-specific L3T4+ T cell-mediated proliferative and interleukin 2 (IL-2)-producing capacities. A single cell suspension of (B6 x bm12)F1 spleen cells was depleted of APC by two round-passages over Sephadex G-10 columns. This APC-depleted fraction of (B6 x bm12)F1 cells failed to stimulate B6 responding cells in mixed lymphocyte reactions (MLR). The addition of recombinant IL-1 to the MLR restored anti-bm12 MLR responses, indicating that APC-depleted (B6 x bm12)F1 cells bear bm12 alloantigens but are unable to stimulate B6 anti-bm12 L3T4+ T cells. A single i.v. administration of APC-depleted (B6 x bm12)F1 cells into B6 mice resulted in almost complete abrogation of the capacity of recipient B6 lymphoid cells to give anti-bm12 MLR and IL2 production. This suppression was bm12 alloantigen-specific and attributed to the elimination or functional impairment of anti-bm12 T cell clones rather than the induction of suppressor cells. The tolerance was also observed in graft-rejection responses. The strikingly prolonged survival of bm12 skin grafts was produced when grafts were implanted into B6 mice which had been presensitized with APC-depleted, but not with untreated (B6 x bm12)F1 spleen cells. These results indicate that allo-class II H-2 antigen-reactive L3T4+ T cells are rendered tolerant by i.v. presensitization with APC-depleted fraction of the corresponding allogeneic cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527264

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Tolerogenicity of resting and activated B cells.

Authors:  K M Gilbert; W O Weigle
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

2.  In vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T-cell help.

Authors:  M A Rees; A S Rosenberg; T I Munitz; A Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes.

Authors:  E T Zambidis; A Kurup; D W Scott
Journal:  Mol Med       Date:  1997-03       Impact factor: 6.354

4.  Peptides of a major histocompatibility complex class I (Kb) molecule cause prolongation of skin graft survival and induce specific down-regulatory T cells demonstrable in the mixed lymphocyte reaction.

Authors:  B D Brondz; D B Kazansky; A D Chernyshova; V S Ivanov
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

Review 5.  Accessory cell-derived signals required for T cell activation.

Authors:  J G Johnson; M K Jenkins
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

6.  Peripheral CD4(+) T-cell tolerance is induced in vivo by rare antigen-bearing B cells in follicular, marginal zone, and B-1 subsets.

Authors:  Susan E Murray; Katelynne Gardner Toren; David C Parker
Journal:  Eur J Immunol       Date:  2013-05-08       Impact factor: 5.532

7.  'Subthreshold stimulation' of allospecific delayed hypersensitivity by corneal allografts.

Authors:  J Y Niederkorn; E Mayhew
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

8.  Induction of T-cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells.

Authors:  S W Chung; R M Gorczynski; I Dziadkowiec; G A Levy
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

9.  Specific CTL activity of CD8+ TCR Vbeta14+ T cell in mouse 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis.

Authors:  Toyoo Nitta; Hisashi Iwata; Yoshio Mori; Hisato Takagi; Toshio Hirota; Kazuto Kanetake; Yutaka Iida; Ken-Ichi Sakamoto; Takuya Yamada; Masanao Saio; Hajime Hirose
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

10.  Recovery of antitumor CD4+ T cell responsiveness, suppressed in the tumor-bearing state, by release from tumor burden.

Authors:  J P Zou; T Nagata; N Yamamoto; S Ono; H Fujiwara; T Hamaoka
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.